









Markets
/
Stocks
/
nasdaq-hypr
/

Hyperfine Inc

HYPR

1.450USD

+0.060+4.32%

Close 09/19, 16:00（ET）Quotes delayed by 15 min

113.94MMarket Cap

LossP/E TTM



Hyperfine Inc

1.450

+0.060+4.32%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score

Currency: USD Updated: 2025-09-19

Key Insights

The company's fundamentals are relatively very healthy. Its valuation is considered undervalued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite a weak stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking

90 / 207

Overall Ranking

202 / 4720

Industry

Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 3 analysts

Buy

Current Rating

1.417

Target Price

+1.92%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks

Hyperfine, Inc. is a health technology company. The Company provides a Swoop Portable Magnetic Resonance Imaging System (Swoop system), which is a portable magnetic resonance imaging (MRI) system capable of providing neuroimaging at the point of care. Its Swoop system produces images at a lower magnetic field strength than conventional MRI scanners. The Swoop system is a portable, ultra-low-field (ULF) MRI device for producing images that display the internal structures of the head where full diagnostic examination is not clinically practical. MRI is used in various clinical settings for medical diagnosis, the staging of disease, and follow-up treatment. It has designed Swoop system to address an unmet need in point-of-care medical imaging through a combination of hardware and artificial intelligence (AI)-powered software services. The Company’s system operates from a Wi-Fi-capable tablet and integrates with picture archiving and communication systems (PACS).

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 89.17% year-on-year.

Growing

The company is in a growing phase, with the latest annual income totaling USD 12.89M.

Undervalued

The company’s latest PE is -2.75, at a low 3-year percentile range.

Institutional Selling

The latest institutional holdings are 12.05M shares, decreasing 22.20% quarter-over-quarter.

Held by The Vanguard

Star Investor The Vanguard holds 3.32M shares of this stock.

Lower Market Activity

The company has less investor interest, with a 20-day turnover ratio of -0.38.

Financial Health

Currency: USD Updated: 2025-09-19

The company's current financial score is 6.50, which is lower than the Healthcare Equipment & Supplies industry's average of 7.32. Its financial status is robust, and its operating efficiency is low. Its latest quarterly revenue reached 2.70M, representing a year-over-year decrease of 25.75%, while its net profit experienced a year-over-year decrease of 9.17%.

Score

Industry at a Glance

Previous score

6.50

Change



Financials

9.49

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

7.42

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

2.77

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

5.73

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

7.09

Key Metrics

Free cash flow

No Data

Company Valuation

Currency: USD Updated: 2025-09-19

The company’s current valuation score is 2.80, which is lower than the Healthcare Equipment & Supplies industry's average of 3.59. Its current P/E ratio is -2.64, which is -48.69% below the recent high of -1.35 and 25.90% above the recent low of -1.95.

Score

Industry at a Glance

Previous score

2.80

Change

1.2

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 90/207

No Data

Earnings Forecast

Currency: USD Updated: 2025-09-19

The company’s current earnings forecast score is 7.33, which is lower than the Healthcare Equipment & Supplies industry's average of 7.70. The average price target for Hyperfine Inc is 1.40, with a high of 2.00 and a low of 0.85.

Score

Industry at a Glance

Previous score

7.33

Change

Support & Resistance

No Data

Analyst Rating

Based on 3 analysts

Buy

Current Rating

1.417

Target Price

+1.92%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

Hyperfine Inc

HYPR

Boston Scientific Corp

BSX

Edwards Lifesciences Corp

Intuitive Surgical Inc

ISRG

Veeva Systems Inc

VEEV

Thermo Fisher Scientific Inc

TMO

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-09-19

The company’s current price momentum score is 8.91, which is higher than the Healthcare Equipment & Supplies industry's average of 6.80. Sideways: Currently, the stock price is trading between the resistance level at 1.57 and the support level at 1.13, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

8.91

Change

0.24

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(1)

Neutral(3)

Buy(2)

Indicators

Value

Direction

MACD(12,26,9)

0.025

Buy

RSI(14)

66.279

Neutral

STOCH(KDJ)(9,3,3)

78.466

Neutral

ATR(14)

0.091

Low Volatility

CCI(14)

80.910

Neutral

Williams %R

11.364

Overbought

TRIX(12,20)

0.639

Sell

StochRSI(14)

100.000

Buy

Moving Average

Sell(0)

Neutral(0)

Buy(6)

Indicators

Value

Direction

MA5

1.410

Buy

MA10

1.360

Buy

MA20

1.287

Buy

MA50

1.180

Buy

MA100

0.944

Buy

MA200

0.946

Buy

Institutional Confidence

Currency: USD Updated: 2025-09-19

The company’s current institutional recognition score is 3.00, which is lower than the Healthcare Equipment & Supplies industry's average of 6.89. The latest institutional shareholding proportion is 19.20%, representing a quarter-over-quarter decrease of 33.60%. The largest institutional shareholder is The Vanguard, holding a total of 3.32M shares, representing 5.23% of shares outstanding, with 4.41% decrease in holdings.

Score

Industry at a Glance

Previous score

3.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

The Vanguard Group, Inc.

Star Investors

3.32M

+4.56%

Fosun International Ltd

1.74M

Rothberg (Jonathan M)

981.21K

+0.67%

Alphabet, Inc.

898.72K

Catalio Capital Management, LP

760.03K

Geode Capital Management, L.L.C.

686.12K

+10.19%

2012 JMR Trust Common, LLC

585.74K

BlackRock Institutional Trust Company, N.A.

575.67K

23rd Century Capital, LLC

440.30K

Risk Assessment

Currency: USD Updated: 2025-09-19

The company’s current risk assessment score is 3.10, which is lower than the Healthcare Equipment & Supplies industry's average of 3.87. The company's beta value is 1.09. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.